StockSelector.com
  Research, Select, & Monitor Monday, August 19, 2019 3:47:14 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Progenics Pharmaceuticals Inc.$3.70$.102.78%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Progenics Pharmaceuticals Inc. has an overall rank of 5346 out of 7126 stocks based on 8 positive rankings and 9 negative rankings.

Positive Rankings
Low Put/Call
Progenics Pharmaceuticals Inc. has a low Put/Call ratio of 0.04 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Progenics Pharmaceuticals Inc. is ranked 101.
Oversold RSI
The 14 Day Relative-Strength Index for Progenics Pharmaceuticals Inc. is 23.7. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Progenics Pharmaceuticals Inc. is ranked 167.
Low vPut/Call
Progenics Pharmaceuticals Inc. has a low Put/Call ratio of 0.14 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Progenics Pharmaceuticals Inc. is ranked 276.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Progenics Pharmaceuticals Inc. is ranked 311.
Oversold Stochastics
Progenics Pharmaceuticals Inc. rank is 334
Historic Revenue Growth
Progenics Pharmaceuticals Inc. rank is 968
Highest Cash Growth
Progenics Pharmaceuticals Inc. rank is 1065
Debt-to-Equity
Progenics Pharmaceuticals Inc. rank is 1406
Negative Rankings
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (100.09%). Among companies that have had their estimates lowerec within the past month, Progenics Pharmaceuticals Inc. is ranked 26.
10 Day Loss
Progenics Pharmaceuticals Inc. rank is 169
Negative Net Margin
Progenics Pharmaceuticals Inc. rank is 345
Price-to-Sales
Progenics Pharmaceuticals Inc. rank is 368
Down EPS Surprise
Progenics Pharmaceuticals Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROE
Progenics Pharmaceuticals Inc. rank is 519
Negative ROA
Progenics Pharmaceuticals Inc. rank is 636
90 Day Loss
Progenics Pharmaceuticals Inc. rank is 1071
Price-to-Book
Progenics Pharmaceuticals Inc. rank is 1426







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.